Moderate Hypofractionation
Moderate Hypofractionation is a radiotherapy regimen within the category of hypofractionated breast radiotherapy that distinguishes itself by delivering moderately reduced treatment fractions—typically 15 to 16 sessions—over a short period, balancing efficacy, toxicity, and patient convenience compared to conventional or ultra-hypofractionated schedules.
318
Publications
23.1K
Citations
2.3K
Authors
649
Institutions
Publications per year
2017–2026
144
318
Joanne Haviland, John R. Owen, John Dewar et al. · The Lancet Oncology · 2013 · 1.5K citations · Full text
Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman et al. · The Lancet · 2019 · 871 citations
1–5 of 318
2.3K
12
h-index
9
h-index
8
h-index
8
h-index
8
h-index
1–5 of 2.3K
649

Institute of Cancer Research
London, United Kingdom
15 h-index
118 publications
23.6K citations

Royal Marsden NHS Foundation Trust
London, United Kingdom
14 h-index
59 publications
4K citations

Sunnybrook Health Science Centre
Toronto, Canada
14 h-index
57 publications
3.6K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
14 h-index
104 publications
7.3K citations

University of Toronto
Toronto, Canada
13 h-index
77 publications
3K citations
Health Sciences Centre
Winnipeg, Canada
12 h-index
49 publications
3.2K citations
University of Pennsylvania
Philadelphia, United States
11 h-index
37 publications
1.6K citations
Ospedale Sacro Cuore Don Calabria
Negrar, Italy
10 h-index
55 publications
1.4K citations
1–8 of 649
111 publications · 6.8K citations
47
h-index
30 publications · 1.7K citations
23
h-index
22 publications · 817 citations
18
h-index
10 publications · 4.8K citations
10
h-index
9 publications · 256 citations
9
h-index
1–5